This company listing is no longer active
Clover Biopharmaceuticals Dirección
Dirección controles de criterios 0/4
Clover Biopharmaceuticals' CEO is Joshua G. Liang, appointed in Dec 2020, has a tenure of 2.75 years. total yearly compensation is CN¥30.29M, comprised of 26.9% salary and 73.1% bonuses, including company stock and options. directly owns 1.48% of the company’s shares, worth HK$18.53M. The average tenure of the management team and the board of directors is 1.7 years and 2 years respectively.
Información clave
Joshua G. Liang
Chief Executive Officer (CEO)
CN¥30.3m
Compensación total
| Porcentaje del salario del CEO | 26.9% |
| Permanencia del CEO | 2.8yrs |
| Participación del CEO | 1.5% |
| Permanencia media de la dirección | 1.7yrs |
| Promedio de permanencia en la Junta Directiva | 2yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -CN¥665m |
| Mar 31 2023 | n/a | n/a | -CN¥2b |
| Dec 31 2022 | CN¥30m | CN¥8m | -CN¥2b |
| Sep 30 2022 | n/a | n/a | -CN¥4b |
| Jun 30 2022 | n/a | n/a | -CN¥6b |
| Mar 31 2022 | n/a | n/a | -CN¥6b |
| Dec 31 2021 | CN¥15m | CN¥8m | -CN¥6b |
| Dec 31 2020 | CN¥4m | CN¥4m | -CN¥913m |
Compensación vs. Mercado: Joshua G.'s total compensation ($USD4.14M) is above average for companies of similar size in the Hong Kong market ($USD335.32K).
Compensación vs. Ingresos: Joshua G.'s compensation has increased whilst the company is unprofitable.
CEO
Joshua G. Liang (30 yo)
2.8yrs
Permanencia
CN¥30,285,000
Compensación
Mr. Joshua G. Liang is Executive Director and Chief Executive Officer at Clover Biopharmaceuticals, Ltd. since December 25, 2020. Mr. Liang is primarily responsible for leading the management and operation...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 4.9yrs | CN¥10.45m | 16.19% CN¥ 203.2m | |
| CEO & Executive Director | 2.8yrs | CN¥30.29m | 1.48% CN¥ 18.5m | |
| Chief Financial Officer | 1.3yrs | sin datos | sin datos | |
| Chief Technology Officer | less than a year | sin datos | sin datos | |
| Director of Investor Relations | less than a year | sin datos | sin datos | |
| Executive Director of Corporate Communications | less than a year | sin datos | sin datos | |
| Chief People Officer | 1.8yrs | sin datos | sin datos | |
| Chief Medical Officer of Vaccine | 2.6yrs | sin datos | sin datos | |
| Chief Technical Operation Officer | no data | sin datos | sin datos | |
| Senior Vice President of Corporate Strategy & Business Development | 1.8yrs | sin datos | sin datos | |
| Senior Vice President of Head of Regulatory Affairs | 1.8yrs | sin datos | sin datos | |
| President of Global Research & Development | 1.6yrs | sin datos | sin datos |
1.7yrs
Permanencia media
53yo
Promedio de edad
Equipo directivo experimentado: 2197's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 4.9yrs | CN¥10.45m | 16.19% CN¥ 203.2m | |
| CEO & Executive Director | 2.8yrs | CN¥30.29m | 1.48% CN¥ 18.5m | |
| Independent Non-Executive Director | 2yrs | CN¥2.21m | 0.011% CN¥ 143.2k | |
| Non-Executive Director | 1.3yrs | CN¥1.30m | 0.039% CN¥ 484.8k | |
| Non-Executive Director | 2.5yrs | CN¥2.20m | 2.18% CN¥ 27.3m | |
| Non-Executive Director | 1.3yrs | CN¥527.00k | 0.0067% CN¥ 84.6k | |
| Independent Non-Executive Director | 2yrs | CN¥2.32m | 0.011% CN¥ 143.2k | |
| Independent Non-executive Director | 2yrs | CN¥2.29m | 0.011% CN¥ 143.2k | |
| Independent Non-Executive Director | 2yrs | CN¥2.21m | 0.011% CN¥ 143.2k |
2.0yrs
Permanencia media
61yo
Promedio de edad
Junta con experiencia: 2197's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.